Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Zhenggang Ren, Jianming Xu, Yuxian Bai, +37

The Lancet Oncology

HepatologyBevacizumab BiosimilarMedicinePathologyVersus Sorafenib +6

Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial

Jianming Xu, Jie Shen, Shanzhi Gu, +26

Clinical Cancer Research

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

Hai‐Dong Zhu, Hai-Liang Li, Mingsheng Huang, +61

Signal Transduction and Targeted Therapy

Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study

Qiuhe Wang, Dongdong Xia, Wei Bai, +57

Journal of Hepatology

Prognostic BiomarkersHepatologyMedicineRecommended Tace CandidatesPathology +6

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

Zhi‐Cheng Jin, Jian-Jia Chen, Xiaoli Zhu, +44

EClinicalMedicine

MedicineImmune Checkpoint InhibitorsImmunologyImmune Checkpoint InhibitorTransarterial Chemoembolization +7

Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study

Zhi‐Cheng Jin, Bin‐Yan Zhong, Jian-Jia Chen, +13

European Radiology

Comparison on hypoglycemic and antioxidant activities of the fresh and dried Portulaca oleracea L. in insulin-resistant HepG2 cells and streptozotocin-induced C57BL/6J diabetic mice

Junfei Gu, Zhiyin Zheng, Jiarui Yuan, +7

Journal of Ethnopharmacology

Diabetes ManagementInsulin-resistant Hepg2 CellsBiochemistryDried PortulacaMedicine +8

Regulation of different components from Ophiopogon japonicus on autophagy in human lung adenocarcinoma A549Cells through PI3K/Akt/mTOR signaling pathway

Juan Chen, Jiarui Yuan, Liqiang Zhou, +9

Biomedicine & Pharmacotherapy

Cell AutophagyMitophagySignal TransductionSignaling PathwayCell Regulation +10

Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations

Ming Zhao, Zhi Guo, Yinghua Zou, +36

Hepatology International

Arterial ChemotherapyHepatologyMedicineLiver CancerOncology +3

Correlation and efficacy of <scp>TACE</scp> combined with lenvatinib plus <scp>PD</scp>‐1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features

Xinhua Zou, Qingyu Xu, Ran You, +1

Cancer Medicine